Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
D036002:ADP Ribose Transferases; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D000939:Epitopes / Q000276:immunology; D005098:Exotoxins / Q000096:biosynthesis; D006801:Humans; D008168:Lung / Q000382:microbiology*; D010447:Peptide Hydrolases / Q000096:biosynthesis; D011552:Pseudomonas Infections / Q000150:complications / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D011710:Pyocyanine / Q000096:biosynthesis; D014611:Vaccination; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D000939:Epitopes; D005098:Exotoxins; D010447:Peptide Hydrolases; D011710:Pyocyanine; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A